The pharmaceutical landscape is seeing a change with the introduction of GLP-1 transdermal systems . These innovative formulations offer a potential approach to providing glucagon-like peptide-1 drugs for https://poppietjfh285948.liberty-blog.com/41226034/glp-1-patches-a-novel-way-to-control-the-condition